Fungal infectious disease
MONDO:0002041An infection caused by a fungus.
Also known as: Fungi caused disease or disorder, Fungi disease or disorder, Fungi infection, Fungi infectious disease, mycosis, fungal infection, infection, fungal, infections, Fungi
293 clinical trials for this condition and its sub-types, 38 tagged with Fungal infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Fungal infectious disease
-
Opportunistic mycosis 0 trials · 147 incl. sub-types
12 sub-types
- Candidiasis 18 trials · 57 incl. sub-types Sub-types →
- Aspergillosis 19 trials · 55 incl. sub-types Sub-types →
- Opportunistic systemic mycosis 0 trials · 23 incl. sub-types Sub-types →
- Zygomycosis 19 trials Sub-types →
- Pneumocystosis 19 trials
- Cryptococcosis 5 trials · 10 incl. sub-types Sub-types →
- Fusariosis 4 trials
- Hyalohyphomycosis 1 trial
- Geotrichosis 0 trials
- Maple bark strippers' lung 0 trials
- Microsporidiosis 0 trials Sub-types →
- Phaeohyphomycosis 0 trials
-
Cutaneous mycosis 1 trial · 118 incl. sub-types
5 sub-types
- Tinea infection 1 trial · 116 incl. sub-types Sub-types →
- Superficial mycosis 0 trials · 88 incl. sub-types Sub-types →
- Dermatomycosis 1 trial Sub-types →
- Cutaneous basidiobolomycosis 0 trials
- Subcutaneous mycosis 0 trials Sub-types →
-
Fungal lung infectious disease 6 trials · 57 incl. sub-types
5 sub-types
- Pulmonary aspergilloma 11 trials · 38 incl. sub-types Sub-types →
- Pneumocystosis 19 trials
- Adiaspiromycosis 0 trials
- Cork-handlers' disease 0 trials
- Maple bark strippers' lung 0 trials
-
Systemic mycosis 27 trials · 54 incl. sub-types
3 sub-types
- Opportunistic systemic mycosis 0 trials · 23 incl. sub-types Sub-types →
- Primary systemic mycosis 0 trials · 9 incl. sub-types Sub-types →
- Disseminated sporotrichosis 0 trials
-
Pneumocystis infectious disease 4 trials · 19 incl. sub-types
1 sub-type
- Pneumocystosis 19 trials
-
Fungal meningitis 3 trials · 10 incl. sub-types
2 sub-types
- Cryptococcal meningitis 7 trials
- Histoplasmosis meningitis 0 trials
-
Fungal infection of eye 0 trials · 7 incl. sub-types
2 sub-types
- Fungal keratitis 6 trials
- Histoplasmosis retinitis 1 trial
-
Scedosporiosis 2 trials
-
Sporotrichosis 1 trial
1 sub-type
- Disseminated sporotrichosis 0 trials
-
Alternariosis 0 trials
1 sub-type
- Phaeohyphomycosis 0 trials
-
Emergomycosis 0 trials
-
Fungal discitis 0 trials
-
Fungal esophagitis 0 trials
1 sub-type
- Esophageal candidiasis 0 trials
-
Fungal gastritis 0 trials
-
Fungal myositis 0 trials
-
Invasive scopulariopsis infection 0 trials
-
Mycotic endocarditis 0 trials
-
Mycotoxicosis 0 trials
1 sub-type
- Ergotism 0 trials
Most studied deeper sub-types
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Stopped earlyThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New pill could fight dangerous fungal infections
Disease control Stopped earlyThis study tested a new oral antifungal drug, ibrexafungerp, for treating serious Candida infections in the blood or internal organs. 68 adults received an IV antifungal followed by either ibrexafungerp or standard oral fluconazole. The trial was stopped early, so the results are…
Phase 3 • Sponsor: Scynexis, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Promising fungal infection treatment study halted early
Disease control Stopped earlyThis study tested whether adding an inhaled medication (PC945) to standard antifungal drugs could help people with a severe, hard-to-treat lung fungal infection called invasive pulmonary aspergillosis. The trial aimed to see if the combination improved survival and response by da…
Phase 3 • Sponsor: Pulmocide Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope against deadly molds? early trial cut short
Disease control Stopped earlyThis study tested a drug called fosmanogepix in 21 adults with invasive mold infections (like Aspergillus or rare molds) who had few other options. The trial was stopped early, so we have limited data on how well it works or its safety.
Phase 2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC